Plasma levels of fibrinogen, factor VIIc and prothrombin fragment F1+2
, a marker of thrombin generation in vivo, were studied in 68 subjects
with serum total cholesterol (TC) levels between 135 and 349 mg/dl bu
t without clinical evidence of cardiovascular disease and other athero
sclerotic risk factors. F1+2 plasma levels were directly correlated wi
th TC (p < 0.0004), low-density lipoprotein cholesterol (LDL-C; p < 0.
0018) and factor VIIc (p < 0.024). Thirty-five subjects with TC greate
r than 249 mg/dl (median value of the whole group) showed higher level
s of F1+2 (p < 0.0001) and fibrinogen (p < 0.0015) than those with TC
lower than 249 mg/dl. In subjects with TC > 249 mg/dl and F1+2 > 1.2 n
M (median value of the whole group), a cholesterol-lowering drug (simv
astatin) was able to reduce F1+2 (p < 0.009) as well as TC and LDL-C.
This study shows a relationship between serum cholesterol and the rate
of thrombin generation supporting the hypothesis that a hypercoagulab
le stale may occur in hypercholesterolemic subjects before the onset o
f clinical evidence of atherosclerotic cardiovascular disease.